PMC:7212965 / 70486-70840
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T165","span":{"begin":197,"end":202},"obj":"Body_part"},{"id":"T166","span":{"begin":255,"end":260},"obj":"Body_part"}],"attributes":[{"id":"A165","pred":"fma_id","subj":"T165","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A166","pred":"fma_id","subj":"T166","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Xu, 202029Guangzhou Eighth People’s Hospital (Guangzhou)GuangdongDates: 1/23/2020-2/4/2020Last follow-up: NR n = 90Survival: NRInclusion: Inpatients with COVID-19 based on RT-PCR who had baseline chest CT.Age: M 50 y (range, 18–86 y)Sex: 56.7% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 5.6% (5)Vomiting: 5.6% (5)Nausea: 2.2% (2) NR"}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T132","span":{"begin":197,"end":202},"obj":"Body_part"},{"id":"T133","span":{"begin":255,"end":260},"obj":"Body_part"}],"attributes":[{"id":"A132","pred":"uberon_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A133","pred":"uberon_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Xu, 202029Guangzhou Eighth People’s Hospital (Guangzhou)GuangdongDates: 1/23/2020-2/4/2020Last follow-up: NR n = 90Survival: NRInclusion: Inpatients with COVID-19 based on RT-PCR who had baseline chest CT.Age: M 50 y (range, 18–86 y)Sex: 56.7% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 5.6% (5)Vomiting: 5.6% (5)Nausea: 2.2% (2) NR"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T348","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"T349","span":{"begin":299,"end":307},"obj":"Disease"}],"attributes":[{"id":"A348","pred":"mondo_id","subj":"T348","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A349","pred":"mondo_id","subj":"T349","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" Xu, 202029Guangzhou Eighth People’s Hospital (Guangzhou)GuangdongDates: 1/23/2020-2/4/2020Last follow-up: NR n = 90Survival: NRInclusion: Inpatients with COVID-19 based on RT-PCR who had baseline chest CT.Age: M 50 y (range, 18–86 y)Sex: 56.7% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 5.6% (5)Vomiting: 5.6% (5)Nausea: 2.2% (2) NR"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T516","span":{"begin":197,"end":202},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T517","span":{"begin":226,"end":228},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T518","span":{"begin":255,"end":260},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T519","span":{"begin":255,"end":260},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":" Xu, 202029Guangzhou Eighth People’s Hospital (Guangzhou)GuangdongDates: 1/23/2020-2/4/2020Last follow-up: NR n = 90Survival: NRInclusion: Inpatients with COVID-19 based on RT-PCR who had baseline chest CT.Age: M 50 y (range, 18–86 y)Sex: 56.7% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 5.6% (5)Vomiting: 5.6% (5)Nausea: 2.2% (2) NR"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53642","span":{"begin":107,"end":109},"obj":"Chemical"},{"id":"T86317","span":{"begin":296,"end":298},"obj":"Chemical"},{"id":"T66147","span":{"begin":352,"end":354},"obj":"Chemical"}],"attributes":[{"id":"A11512","pred":"chebi_id","subj":"T53642","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A99726","pred":"chebi_id","subj":"T86317","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A13322","pred":"chebi_id","subj":"T66147","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"}],"text":" Xu, 202029Guangzhou Eighth People’s Hospital (Guangzhou)GuangdongDates: 1/23/2020-2/4/2020Last follow-up: NR n = 90Survival: NRInclusion: Inpatients with COVID-19 based on RT-PCR who had baseline chest CT.Age: M 50 y (range, 18–86 y)Sex: 56.7% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 5.6% (5)Vomiting: 5.6% (5)Nausea: 2.2% (2) NR"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T321","span":{"begin":299,"end":307},"obj":"Phenotype"},{"id":"T322","span":{"begin":317,"end":325},"obj":"Phenotype"},{"id":"T323","span":{"begin":335,"end":341},"obj":"Phenotype"}],"attributes":[{"id":"A321","pred":"hp_id","subj":"T321","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A322","pred":"hp_id","subj":"T322","obj":"http://purl.obolibrary.org/obo/HP_0002013"},{"id":"A323","pred":"hp_id","subj":"T323","obj":"http://purl.obolibrary.org/obo/HP_0002018"}],"text":" Xu, 202029Guangzhou Eighth People’s Hospital (Guangzhou)GuangdongDates: 1/23/2020-2/4/2020Last follow-up: NR n = 90Survival: NRInclusion: Inpatients with COVID-19 based on RT-PCR who had baseline chest CT.Age: M 50 y (range, 18–86 y)Sex: 56.7% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 5.6% (5)Vomiting: 5.6% (5)Nausea: 2.2% (2) NR"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T608","span":{"begin":0,"end":72},"obj":"Sentence"},{"id":"T609","span":{"begin":73,"end":138},"obj":"Sentence"},{"id":"T610","span":{"begin":139,"end":210},"obj":"Sentence"},{"id":"T611","span":{"begin":211,"end":238},"obj":"Sentence"},{"id":"T612","span":{"begin":239,"end":308},"obj":"Sentence"},{"id":"T613","span":{"begin":309,"end":326},"obj":"Sentence"},{"id":"T614","span":{"begin":327,"end":342},"obj":"Sentence"},{"id":"T615","span":{"begin":343,"end":354},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Xu, 202029Guangzhou Eighth People’s Hospital (Guangzhou)GuangdongDates: 1/23/2020-2/4/2020Last follow-up: NR n = 90Survival: NRInclusion: Inpatients with COVID-19 based on RT-PCR who had baseline chest CT.Age: M 50 y (range, 18–86 y)Sex: 56.7% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 5.6% (5)Vomiting: 5.6% (5)Nausea: 2.2% (2) NR"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"2247","span":{"begin":28,"end":34},"obj":"Species"},{"id":"2431","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"2432","span":{"begin":299,"end":307},"obj":"Disease"},{"id":"2433","span":{"begin":335,"end":341},"obj":"Disease"}],"attributes":[{"id":"A2247","pred":"tao:has_database_id","subj":"2247","obj":"Tax:9606"},{"id":"A2431","pred":"tao:has_database_id","subj":"2431","obj":"MESH:C000657245"},{"id":"A2432","pred":"tao:has_database_id","subj":"2432","obj":"MESH:D003967"},{"id":"A2433","pred":"tao:has_database_id","subj":"2433","obj":"MESH:D009325"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Xu, 202029Guangzhou Eighth People’s Hospital (Guangzhou)GuangdongDates: 1/23/2020-2/4/2020Last follow-up: NR n = 90Survival: NRInclusion: Inpatients with COVID-19 based on RT-PCR who had baseline chest CT.Age: M 50 y (range, 18–86 y)Sex: 56.7% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 5.6% (5)Vomiting: 5.6% (5)Nausea: 2.2% (2) NR"}